Feedback / Questions
soquelitinib (CPI-818) - Corvus Pharma
https://www.globenewswire.com/news-release/2025/06/25/3105021/0/en/Corvus-Pharmaceuticals-Announces-Partner-Angel-Pharmaceuticals-Received-IND-Approval-for-a-Phase-1b-2-Clinical-Trial-of-Soquelitinib-in-China-for-the-Treatment-of-Atopic-Dermatitis.html
Jun 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next